These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
992 related items for PubMed ID: 18520972
1. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006. Espié E, Grimont F, Mariani-Kurkdjian P, Bouvet P, Haeghebaert S, Filliol I, Loirat C, Decludt B, Minh NN, Vaillant V, de Valk H. Pediatr Infect Dis J; 2008 Jul; 27(7):595-601. PubMed ID: 18520972 [Abstract] [Full Text] [Related]
2. Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006. Hedican EB, Medus C, Besser JM, Juni BA, Koziol B, Taylor C, Smith KE. Clin Infect Dis; 2009 Aug 01; 49(3):358-64. PubMed ID: 19548834 [Abstract] [Full Text] [Related]
9. Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000-2010: epidemiologic features and comparison with E. coli O157 infections. Gould LH, Mody RK, Ong KL, Clogher P, Cronquist AB, Garman KN, Lathrop S, Medus C, Spina NL, Webb TH, White PL, Wymore K, Gierke RE, Mahon BE, Griffin PM, Emerging Infections Program Foodnet Working Group. Foodborne Pathog Dis; 2013 May 15; 10(5):453-60. PubMed ID: 23560425 [Abstract] [Full Text] [Related]
10. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. J Infect Dis; 2002 Aug 15; 186(4):493-500. PubMed ID: 12195376 [Abstract] [Full Text] [Related]
12. Diarrheagenic E. coli in hospitalized patients: special reference to Shiga-like toxin producing Escherichia coli. Lanjewar M, De AS, Mathur M. Indian J Pathol Microbiol; 2010 Aug 15; 53(1):75-8. PubMed ID: 20090227 [Abstract] [Full Text] [Related]
13. [The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission]. Rivas M, Miliwebsky E, Chinen I, Deza N, Leotta GA. Medicina (B Aires); 2006 Aug 15; 66 Suppl 3():27-32. PubMed ID: 17354474 [Abstract] [Full Text] [Related]
14. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection. Bruyand M, Mariani-Kurkdjian P, Gouali M, de Valk H, King LA, Le Hello S, Bonacorsi S, Loirat C. Med Mal Infect; 2018 May 15; 48(3):167-174. PubMed ID: 29054297 [Abstract] [Full Text] [Related]
19. [Hemolytic uremic syndrome associated to shigatoxin producing Escherichia coli in Chilean children: clinical and epidemiological aspects]. Prado J V, Cavagnaro S M F, Grupo de Estudio de Infecciones por STEC. Rev Chilena Infectol; 2008 Dec 15; 25(6):435-44. PubMed ID: 19194606 [Abstract] [Full Text] [Related]